ODDB.org: Open Drug Database | Drugs

Biotest (Schweiz) AG - Varitect CP, Lösung zur intravenösen Injektion

Swissmedic Registration	59451	Sequence	01
Product name	Varitect CP	Description	Lösung zur intravenösen Injektion
ATC-Classification	J06BB03	ATC-Description	Varicella/Zoster Immunoglobulin
Introduction of Sequence	13.01.2009

Composition

immunoglobulinum humanum varicellae 25 U.I. corresp. proteina plasmatis humani 50 mg ex illo immunoglobulinum humanum normale (IgG1: ca. 62 %, IgG2: ca. 33 %, IgG3: ca. 3 %, IgG4: ca. 2 %) 96 %, immunoglobulinum humanum A max. 2 mg, glycinum, aqua q.s. ad solutionem pro 1 ml.

Packungsbestandteile

Galenic Form

Excipiens

Active Agent	Dose
	96 %/ml

BAG: Active Agent	Dose
	1250 UI

Inactive agents	Dose
Glycin
	2 mg/ml

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	Vial(s) à 125 IE	136.61	165.00	B	SL	No
002	500 IE	514.95	576.45	B	SL	No
003	1250 IE	1203.80	1325.60	B	SL	No

2025	©ywesee GmbH